Cycling activity of benign prostatic epithelial cells during long-term androgen blockade: Evidence for self-renewal of luminal cells

Journal of Pathology

Volumn 186, Issue 4, 1998, Pages 406-409

  Van Der Kwast, Theodorus H ^a   Têtu, Bernard ^b   Raoul Suburu, E ^b   Gomez, José ^b   Lemay, Martin ^b   Labrie, Fernand ^b  

^a ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

^b LAVAL UNIVERSITY   (Canada)

Author keywords

Androgen antagonists; Immunohistochemistry; LHRH agonist; Proliferation; Prostate; Regeneration; Stem cells

Indexed keywords

ANDROGEN; FLUTAMIDE;

ANDROGEN BLOOD LEVEL; ARTICLE; CELL PROLIFERATION; CELL REGENERATION; CLINICAL ARTICLE; HORMONAL REGULATION; HORMONE INHIBITION; HUMAN; MALE; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE HYPERTROPHY; PROSTATECTOMY;

ANDROGEN ANTAGONISTS; BIOPSY, NEEDLE; CELL DIVISION; CHEMOTHERAPY, ADJUVANT; FLUTAMIDE; GONADOTROPIN-RELEASING HORMONE; HUMANS; IMMUNOENZYME TECHNIQUES; MALE; NEOADJUVANT THERAPY; PROSTATE; PROSTATECTOMY; PROSTATIC NEOPLASMS;

EID: 0032413997     PISSN: 00223417     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9896(199812)186:4<406::AID-PATH205>3.0.CO;2-L     Document Type: Article

References (16)

1. Drawer MK, Peehl DM, Stanley TA, Bostwick DG. Keratin immunoreactivity in the benign and neoplastic human prostate. Cancer Res 1985; 45: 3663-3667.
2. Krijnen JLM, Janssen PJA, Ruizeveld de Winter JA, Van Krimpen H, Schröder FH, Van der Kwast TH. Do neuroendocrine cells in human prostate cancer express androgen receptor? Histochemistry 1993; 100: 393-398.
3. Janssen PJA, Brinkmann AO, Boersma WJ, Van der Kwast TH. Immunohistochemical detection of the androgen receptor with monoclonal antibody F39.4 in routinely processed, paraffin-embedded human tissues after microwave pretreatment. J Histochem Cytochem 1994; 42: 1169-1175.
4. Vaillancourt L, Têtu B, Fradet Y, et al. Effect of neoadjuvant endocrine therapy (CAB) on normal prostate and prostatic carcinoma. Am J Surg Pathol 1996; 20: 86-93.
5. Montironi R, Magi-Galluzzi C, Muzzonigro G, Prete E, Polito M, Fabris G. Effects of combination endocrine treatment on normal prostate, prostatic intra-epithelial neoplasia, and prostatic adenocarcinoma. J Clin Pathol 1994; 47: 906-913.
6. Berges RR, Furuya Y, Remington L, English HF, Jacks T, Isaacs JT. Cell proliferation, DNA repair, and p53 function are not required for programmed death of prostatic glandular cells induced by androgen ablation. Proc Natl Acad Sci USA 1993; 90: 8910-8914.
7. Evans GS, Chandler JA. Cell proliferation studies in the rat prostate: II. The effects of castration and androgen-induced regeneration upon basal and secretory cell proliferation. Prostate 1987; 11: 339-351.
8. Bonkhoff H, Remberger K. Differentiation pathways and histogenetic aspects of normal and abnormal prostatic growth: a stem cell model. Prostate 1996; 28: 98-106.
9. Verhagen APM, Aalders TW, Ramaekers FCS, Debruyne FMJ, Schalken J. Differential expression of keratins in the basal and luminal compartments of rat prostatic epithelium during degeneration and regeneration. Prostate 1988; 13: 25-38.
10. Evans GS, Chandler JA. Cell proliferation studies in rat prostate I. The proliferative role of basal and secretory epithelial cells during normal growth. Prostate 1987; 10: 163-178.
11. Gallee MPW, Visser-De Jong E, Ten Kate FJW, Schroeder FH, Van der Kwast TH. Monoclonal antibody Ki-67 defined growth fraction in benign prostatic hyperplasia and prostatic cancer. J Urol 1989; 142: 1342-1345.
12. Montironi R, Muzzonigro G, Magi Galluzzi C, Giannullis I, Diamanti L, Polito M. Effect of LHRH agonist and flutamide (combination endocrine therapy) on the frequency and localization of proliferating cell nuclear anticen and apoptotic bodies in prostatic hyperplasia. J Urol Pathol 1994; 2: 161-171.
13. English HF, Santen RJ, Isaacs JT. Response of glandular versus basal rat ventral prostatic epithelial cells to androgen withdrawal and replacement. Prostate 1987; 11: 229-242.
14. Westin P, Stattin P, Damber J-E, Bergh A. Castration therapy rapidly induces apoptosis in a minority and decreases cell proliferation in a majority of human prostatic tumors. Am J Pathol 1995; 146: 1368-1375.
15. Bonkhoff H, Remberger K. Widespread distribution of nuclear androgen receptors in the basal cell layer of the normal, hyperplastic, and neoplastic human prostate. Virchows Arch A 1993; 423: 291-294.
16. Pierce GB. Neoplasms, differentiation and mutations. Am J Pathol 1974; 77: 103-118.